HawkInsight

  • Contact Us
  • App
  • English

Aclaris Therapeutics files to sell 35.56M shares of common stock by selling shareholders

Aclaris Therapeutics (NASDAQ:ACRS) filed a prospectus related to the offer and resale of up to about 35.56 million shares of common stock.This prospectus is not an offer to sell.The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder.Filing

Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.

NewFlashHawk Insight
More